Menu

PROGRAM

All Times PACIFIC. Program Subject to Change

FRIDAY, March 13, 2026

11:00am-12:00pm

Registration, Coffee, Visit Exhibits

12:00-1:00pm

Product Theatre Luncheon - Non-CME
Title TBD

1:00-1:15pm

Coffee Break and Visit Exhibits


SESSION I

1:15-1:25pm

Introduction to the 30th Annual Symposium: Heart Failure 2026 – An Update on Therapy
Uri Elkayam, MD, FACC

1:25-1:45pm

Recommendations for the Management of Heart Failure in Patients with Chronic Kidney Disease
Maria Rosa Costanzo, MD

1:45-2:05pm

Balancing GDMT and Hyperkalemia
Ileana L. Piña, MD

2:05-2:25pm

Digitoxin in Heart Failure: A Comeback for Digitalis?
Tien Ng, PharmD

2:25-2:45pm

Introducing Finerenone: A New Drug for the Management of Heart Failure and Chronic Kidney Disease
Akshay Desai, MD

2:45-3:05pm

Vericiguat in Heart Failure: When and How to Use It
Barry Greenberg, MD

3:05-3:25pm

The Contemporary Management of HFpEF
Akshay Desai, MD

3:25-3:40pm

Coffee Break and Visit Exhibits


SESSION II

3:40-4:00pm

Our Journey with Diuretics: 240 Years, and How Far Have We Come?
Marvin Konstam, MD

4:00-4:20pm

Treating Congestion in Patients with Acute Decompensated Heart Failure: Where Are We Now? Where Are We Going?
William Abraham, MD

4:20-4:40pm

Releasing the Brakes on the Immune System in Cancer: Implications in Myocarditis and Beyond
Eric Yang, MD

4:40-5:00pm

Clinical Experience with the Use of Myosin Inhibitors in the Treatment of Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy
Jessica Wang, MD

5:00-5:20pm

Contemporary Management of Obesity in Patients with Heart Failure
Norman Lepor, MD

5:20pm

Adjourn


SATURDAY, March 14, 2026

7:00am

Registration Open

7:15-7:45am

Case Discussion
Uri Elkayam, MD; Maria Rosa Costanzo, MD; Barry Greenberg, MD

7:45-8:45am

Product Theatre Breakfast - Non-CME
Title TBD

8:45-9:00am

Break and Visit the Exhibits


SESSION III

9:00-9:15am

Introduction to Day Two: 30th Annual Symposium: Heart Failure 2026 - An Update on Therapy
Uri Elkayam, MD

9:15-9:35am

GDMT for Chronic HFrEF: How to Maximize the Benefits?
Gregg Fonarow, MD

9:35-9:55am

Cardiogenic Shock: Hemodynamic Classification and Management
Rola Khedraki, MD

9:55-10:15am

Percutaneous Coronary Interventions in Ischemic Cardiomyopathy – Does It Work?
Christina Economides, MD

10:15-10:35am

Bio-Omics in Heart Failure Diagnosis and Therapy
Kirkwood Adams, MD

10:35-10:55am

Break and Visit the Exhibits


SESSION IV

10:55-11:15am

Genetic Testing for Cardiomyopathy
Josh Hare, MD

11:15-11:35am

Gene Therapy for Patients with Cardiomyopathy
Barry Greenberg, MD

11:35-11:55am

Stem Cell Therapy for the Management of Myocardial Disease: A Status Report
Josh Hare, MD

11:55-12:15pm

Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy
Uri Elkayam, MD

12:15-12:35pm

Update on the Management of Atrial Fibrillation in Patients with Heart Failure
Anil Bhandari, MD

12:35-1:35pm

Product Theatre Luncheon - Non-CME
Title TBD

1:35-1:50pm

Break and Visit the Exhibits


SESSION V

1:50-2:20pm

KEYNOTE LECTURE
30 Years of Innovation in the Management of Heart Failure: A Perspective
Clyde Yancy, MD

2:20-2:40pm

Bromocriptine in the Management of Peripartum Cardiomyopathy: Pathophysiologic Mechanism and Available Data
Uri Elkayam, MD

2:40-3:00pm

What Is New in Myocarditis: An Update from the ESC 2025 Guidelines
Leslie Cooper, MD

3:00-3:20pm

Pulmonary Hypertension: New Drugs and How to Use Them
Thomas Heywood, MD

3:20-3:40pm

Innovations in Device Therapy for Heart Failure
William Abraham, MD

3:40-4:00pm

Break and Visit Exhibits

SESSION VI

4:00-4:20pm

The Use of AI in the Management of Heart Failure
Nir Uriel, MD

4:20-4:40pm

Autonomic Modulation in Heart Failure Treatment: Where Are We and Where Are We Heading?
Marvin Konstam, MD

4:40-5:00pm

LVAD vs Heart Transplantation: A Perspective
Nir Uriel, MD

5:00-5:20pm

Individual Selection of Drug Therapy in Patients with Transthyretin (TTR) Amyloidosis
Mazen Hanna, MD

5:20pm

Adjourn